Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayant Narang

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Neuro-Oncology|August 4, 2010
Tumor vascular leakiness and blood volume estimates in oligodendrogliomas using perfusion CT: an analysis of perfusion parameters helping further characterize genetic subtypes as well as differentiate from astroglial tumorsJayant Narang, Rajan Jain, Lisa Scarpace, et al.
Magnetic Resonance in Medicine|December 1, 2011
Model selection for DCE-T1 studies in glioblastomaHassan Bagher-Ebadian, Rajan Jain, Siamak P Nejad-Davarani, et al.
Radiology|December 15, 2012
Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkersRajan Jain, Laila Poisson, Jayant Narang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2022
Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2-Technical)Fabien Ricard, Sally Barrington, Ron Korn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2022
Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1-Clinical)Fabien Ricard, Bruce Cheson, Sally Barrington, et al.
Journal for Immunotherapy of Cancer|March 27, 2026
CD8 PET imaging with [<sup>89</sup>Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate studyMichael A Postow, Peter D Zang, Sumanta K Pal, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Neuro-Oncology|August 4, 2010
Tumor vascular leakiness and blood volume estimates in oligodendrogliomas using perfusion CT: an analysis of perfusion parameters helping further characterize genetic subtypes as well as differentiate from astroglial tumorsJayant Narang, Rajan Jain, Lisa Scarpace, et al.
Magnetic Resonance in Medicine|December 1, 2011
Model selection for DCE-T1 studies in glioblastomaHassan Bagher-Ebadian, Rajan Jain, Siamak P Nejad-Davarani, et al.
Radiology|December 15, 2012
Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkersRajan Jain, Laila Poisson, Jayant Narang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2022
Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2-Technical)Fabien Ricard, Sally Barrington, Ron Korn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2022
Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1-Clinical)Fabien Ricard, Bruce Cheson, Sally Barrington, et al.
Journal for Immunotherapy of Cancer|March 27, 2026
CD8 PET imaging with [<sup>89</sup>Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate studyMichael A Postow, Peter D Zang, Sumanta K Pal, et al.
Pageof 2